January 28, 2026

How to embrace interventional glaucoma "IG" in your practice with iTrack Advance

Join us for a deep dive into canaloplasty in the era of interventional glaucoma or IG.

The Ophthalmologist

January 15, 2026

NPs Top US Jobs List Again

The nurse practitioner profession claims the No. 1 spot across three categories in the U.S. News & World Report 2026 Best Jobs rankings for the third consecutive year.

Conexiant

January 13, 2026

UCI Health Chao Family Comprehensive Cancer Center among the nation’s best

UCI Health’s Chao Family Comprehensive Cancer Center has been named one of the nation’s top cancer programs.

UCI Health

January 12, 2026

Personalizing Corneal Cross-Linking

How tailored approaches to CXL are transforming how we treat keratoconus and other corneal ectasias

The Ophthalmologist

January 08, 2026

How You Are Often the Biggest Bottleneck to Growth

Learn how top-performing surgeons create systems, scorecards, and accountability loops that scale results, not dependency

The Ophthalmologist

January 05, 2026

Marcos A. Nores, M.D., Joins Baptist Health Heart & Vascular Care as Medical Director of Lynn Heart & Vascular Institute

Marcos A. Nores, M.D., board-certified cardiac surgeon, has joined Baptist Health Heart & Vascular Care as medical director of Christine E. Lynn Heart & Vascular Institute at Boca Raton Regional Hospital, part of Baptist Health.

Baptist Health South Florida

January 05, 2026

Preoperative PAXG vs mFOLFIRINOX in Pancreatic Ductal Adenocarcinoma

As reported in The Lancet by Reni et al, analysis of the first randomization in an Italian 2 × 2 factorial phase III trial (PACT-21 CASSANDRA) has shown better event-free survival with preoperative PA...

The ASCO Post

January 05, 2026

Why OBs Are Rethinking Where to Practice

Abortion bans and burnout are driving upheaval in Iowa’s OB-GYN workforce.

KFF Health News

January 02, 2026

Curative Treatment After First-Line Immunotherapy Improves Survival in HCC

Curative treatment—resection, transplantation, and/or local ablation—following first-line immunotherapy is infrequently received, but when it was utilized, it significantly improved overall survival o...

The ASCO Post